Copaxone

Treatment Effectiveness

User reported effectiveness ratings Copaxone for various conditions.

Conditions	Major Improvement	Moderate Improvement	Much Worse	No Effect	Worse	Responses
Chronic Cerebrospinal Venous Insufficiency (CCSVI)	0	0	0	0	0	0
Multiple Sclerosis	9%	19%	4%	60%	9%	112
Neurological Problems and Chronic Pain	0%	0%	44%	44%	11%	9
Neuropathy	0%	33%	17%	33%	17%	6

User-reported side effects of Copaxone

Side Effect	Percent of Reports Copaxone
Nervousness	37%
Diarrhea	8%
Depression	37%
Abnormal Dreams	20%
Confusion	27%
Crossed Eyes	0%
Difficulty Speaking	20%
Ear Pain	4%
Flushing	42%
Immediate Post Injection Reaction	100%
Loss of Appetite	23%
Pain in the Back, Neck, or Any Other Part of the Body	33%
Pain, Redness, Swelling, Itching, or Lump in the Place Where You Injected Glatiramer	79%
Painful or Changed Menstrual Periods	4%
Purple Patches on Skin	31%
Severe Headache	24%
Shaking Hands That You Cannot Control	21%
Sweating	24%
Swelling of the Hands, Feet, Ankles, or Lower Legs	29%
Tightness in Muscles	44%
Urgent Need to Urinate or Defecate	32%
Vaginal Itching and Discharge	8%
Vomiting	0%
Weakness	48%
Weight Gain	19%
White Patches in the Mouth	4%
Nausea	8%
Joint Pain	8%

Below is the degree of change seen after Copaxone is higher than average.

Don't see what you're looking for?

Create a study and help us eradicate suffering!

Outcomes

Below is the change in the listed outcome after is higher than average.

Sort by Effect Size

Sort by Confidence

% Change from Baseline*

Change in the listed outcome after is higher than average.

Property	Value
Variable Name	Copaxone
Aggregation Method	SUM
Analysis Performed At	2020-04-03
Duration of Action	21 days
Filling Value	0
Minimum Allowed Value	0 count
Number of Aggregate Predictors	0
Number of Aggregate Outcomes	0
Number of Measurements	0
Number of Measurements (including those generated by tagged, joined, or child variables)	0
Public	true
Onset Delay	30 minutes
Unit	Count
User Variables	0
Variable Category	Treatments
Variable ID	93040